Hap Trading, LLC G1 Therapeutics, Inc. Call Options Transaction History

Hap Trading, LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 13, 2024	BUY	$2.1 - $4.83 $840,000 - $1.93 Million	400,000 New	400,000 $100 Million
Q1 2023 May 12, 2023	SELL	$2.57 - $8.16 $3,854 - $12,240	-1,500 Reduced 4.76%	30,000 $0
Q4 2022 Feb 14, 2023	BUY	$5.19 - $13.5 $163,485 - $425,250	31,500 New	31,500 $17,000
Q1 2022 May 12, 2022	SELL	$7.6 - $11.02 $89,680 - $130,036	-11,800 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$10.16 - $16.17 $3,048 - $4,851	-300 Reduced 2.48%	11,800 $6,000
Q3 2021 Nov 10, 2021	SELL	$13.16 - $22.47 $25,004 - $42,693	-1,900 Reduced 13.57%	12,100 $2,000
Q2 2021 Aug 11, 2021	BUY	$19.57 - $26.32 $46,968 - $63,168	2,400 Added 20.69%	14,000 $21,000
Q1 2021 May 14, 2021	BUY	$17.58 - $32.59 $203,927 - $378,044	11,600 New	11,600 $13,000

3.55M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.